By combining its CMOS platform with on-chip microfluidics and electrical/photonic sensors, imec develops chips for fast and accurate detection of cells, DNA, small molecules, antibodies, ...
Biosensors that use bioreceptors, transducers and electronics to determine the presence and/or amount of an analyte have been around for decades. They are essential for diagnosis, monitoring of diseases and their treatments, biomedical research and drug discovery, ...
More recently, biosensor technology is making its way out of the research labs and can be found in:
These new applications, as well as improvements of existing systems, are enabled by advances in nanotechnology that lead to smaller form factors, lower costs, and faster results. At imec, we leverage our wide-ranging infrastructure and expertise to support our partners in further pushing those boundaries.
The advantages of shrinking the components of a biosensing system go far beyond more compact form factors. They also include:
Finally, the combination of biosensors and nanotechnology allows the integration of various components on so-called lab-on-a-chips that are mass-producible. Driving down costs and raising the prospects of widely available personalized medicine.
Imec is one of the world’s few R&D centers that houses all the disciplines that are needed to develop such biosensor chips:
Moreover, imec draws upon its infrastructure and expertise to develop biosensor chips that are compatible with standard semiconductor manufacturing flows. Making it easy to scale up from prototyping to low- and even high-volume manufacturing.
Want access to our biosensor technology portfolio for the development of your solution?